229 related articles for article (PubMed ID: 36721820)
1. Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line.
Golbashirzadeh M; Heidari HR; Talebi M; Yari Khosroushahi A
Adv Pharm Bull; 2023 Jan; 13(1):176-187. PubMed ID: 36721820
[No Abstract] [Full Text] [Related]
2. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis.
Golbashirzadeh M; Heidari HR; Aghamolayi AA; Fattahi Y; Talebi M; Khosroushahi AY
Med Oncol; 2023 Aug; 40(10):279. PubMed ID: 37632628
[TBL] [Abstract][Full Text] [Related]
3. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
[TBL] [Abstract][Full Text] [Related]
4. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
6. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
7. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
8. ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance.
Sun Y; Qiao Y; Liu Y; Zhou J; Wang X; Zheng H; Xu Z; Zhang J; Zhou Y; Qian L; Zhang C; Lou H
Redox Biol; 2021 Jul; 43():101977. PubMed ID: 33905957
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells.
Liang Z; Zhao W; Li X; Wang L; Meng L; Yu R
Biochem Biophys Res Commun; 2021 Sep; 569():79-85. PubMed ID: 34237431
[TBL] [Abstract][Full Text] [Related]
11. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
Cheng Q; Bao L; Li M; Chang K; Yi X
J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617
[TBL] [Abstract][Full Text] [Related]
12. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
13. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy.
Li J; Yuan J; Li Y; Wang J; Xie Q; Ma R; Wang J; Ren M; Lu D; Xu Z
Phytomedicine; 2022 Nov; 106():154411. PubMed ID: 36030746
[TBL] [Abstract][Full Text] [Related]
14. Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis.
Yan WY; Cai J; Wang JN; Gong YS; Ding XB
Neoplasma; 2022 May; 69(3):648-656. PubMed ID: 35330996
[TBL] [Abstract][Full Text] [Related]
15. Role of Escin in breast cancer therapy: potential mechanism for inducing ferroptosis and synergistic antitumor activity with cisplatin.
Li C; He Z; Yao F; Liao S; Sun K; Sun S; Li Z; Wang Z
Apoptosis; 2023 Aug; 28(7-8):1154-1167. PubMed ID: 37149513
[TBL] [Abstract][Full Text] [Related]
16. [Effect and Involved Mechanism of RSL3-induced Ferroptosis in Acute Leukemia Cells MOLM13 and Drug-resistant Cell Lines].
Cheng L; Jin X; Lu WY; Sun R; Cao YQ; Wei YX; Wang LQ; He XY; Yuan T; Meng JX; Zhao MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1109-1118. PubMed ID: 34362489
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
18. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4.
Zhang W; Jiang B; Liu Y; Xu L; Wan M
Free Radic Biol Med; 2022 Feb; 180():75-84. PubMed ID: 35038550
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis.
Zhao Y; Ren P; Yang Z; Wang L; Hu C
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36453257
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice.
Liu Z; Zhang H; Hong G; Bi X; Hu J; Zhang T; An Y; Guo N; Dong F; Xiao Y; Li W; Zhao X; Chu B; Guo S; Zhang X; Chai R; Fu X
Mol Ther; 2024 May; 32(5):1387-1406. PubMed ID: 38414247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
